EPSTI1

Across TCGA pan-cancer cohorts, EPSTI1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated EPSTI1 data layer compared with 22 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher EPSTI1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EPSTI1 expression acts as an unfavorable survival marker.

COAD and BLCA are the cancer types where EPSTI1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	II,III,IV	0.213	0.794	<.001	27	view →
BLCA	DFS	Median	All	0.163	0.625	.018	15	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

EPSTI1–COAD (OS)

Open the COAD breakdown →